Chk1 as a new therapeutic target in triple-negative breast cancer.
about
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapyChk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer.Chk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers.Inhibition of Chk1 with the small molecule inhibitor V158411 induces DNA damage and cell death in an unperturbed S-phase.Potential effect of smoking on semen quality through DNA damage and the downregulation of Chk1 in sperm.Checkpoint kinase 1 expression is an adverse prognostic marker and therapeutic target in MYC-driven medulloblastomaCheckpoint kinase 1 inhibition sensitises transformed cells to dihydroorotate dehydrogenase inhibition.DNA methyltransferase 3a modulates chemosensitivity to gemcitabine and oxaliplatin via CHK1 and AKT in p53‑deficient pancreatic cancer cells.MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway
P2860
Q26745686-BE635151-207A-4BD5-A8D6-6EB564C938D8Q34028486-DFFEF03D-4A58-4A15-9D02-F32F9FF85E28Q34062570-9BBF06FC-B883-4FCC-9FFE-BD4925A8AAD4Q36187661-92393CF8-3DC5-41AF-B30C-6E8495B9F664Q37032228-2AD076AF-B74C-41DE-B400-565E736A9CA1Q42324653-13526E57-FF65-4B8C-8A29-556450B7D14BQ47100853-17F2CF20-568D-49F7-A42D-819A81BE7E6EQ47634492-BFAED893-4EB7-4D13-B89D-832AE0C017C2Q57470595-E8ACA5DE-3D32-4F6A-87FF-93569A5D27FC
P2860
Chk1 as a new therapeutic target in triple-negative breast cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Chk1 as a new therapeutic target in triple-negative breast cancer.
@en
Chk1 as a new therapeutic target in triple-negative breast cancer.
@nl
type
label
Chk1 as a new therapeutic target in triple-negative breast cancer.
@en
Chk1 as a new therapeutic target in triple-negative breast cancer.
@nl
prefLabel
Chk1 as a new therapeutic target in triple-negative breast cancer.
@en
Chk1 as a new therapeutic target in triple-negative breast cancer.
@nl
P2093
P50
P1433
P1476
Chk1 as a new therapeutic target in triple-negative breast cancer.
@en
P2093
Aïcha Goubar
Cécile Vicier
Céline Lefèbvre
Frédéric Commo
Laurence Albiges
Mahasti Saghatchian
Philippe Dessen
Samar Alsafadi
Suzette Delaloge
Virginie Quidville
P304
P356
10.1016/J.BREAST.2014.02.004
P577
2014-03-15T00:00:00Z